SCM
ALBO

Segantii Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Segantii Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,120
Closed -$51K – 299
2017
Q1 		$51K Buy
+2,120
New +$46.1K 0.01% 276

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Segantii Capital Management's ALBO Position: Q2 2017 in Review

Segantii Capital Management sold out of Albireo Pharma Inc (ALBO) in Q2 2017, closing a stake of 2,120 shares — an estimated $51K sold.

Segantii Capital Management first reported a position in ALBO in Q1 2017 and held it in 1 quarter. The position peaked at $51K in Q1 2017. 24 funds tracked by Wall St. Rank hold ALBO as of Q2 2017.

  • Segantii Capital Management reported no remaining Albireo Pharma Inc position as of Q2 2017 after selling out during the quarter.
  • Segantii Capital Management sold 2,120 Albireo Pharma Inc shares in Q2 2017, an estimated $51K.
  • Segantii Capital Management first reported a position in Albireo Pharma Inc in Q1 2017 and held it in 1 quarter.
  • Segantii Capital Management's Albireo Pharma Inc position peaked at $51K in Q1 2017.
  • 24 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2017.

Based on Segantii Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.